Plenty of COVID-19 Vaccine Coming, Fauci Says
When a COVID-19 vaccine is approved, there should be plenty of it available.
Vaccination
Early Data Show Investigational ChAdOx1 nCoV-19 Vaccine Safe, Immunogenic
Interim results from the phase 1/2 COV001 trial evaluating the vaccine candidate ChAdOx1 nCoV-19 (AZD1222) showed that vaccination led to strong immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in all evaluated participants.
COVID-19 Vaccine Initiative May Favor Rich Countries
A global COVID-19 vaccine initiative has been formed with the objective of ensuring fair distribution of vaccines worldwide, but it may benefit rich countries more than poor nations.
Immune Responses Observed in All Participants Dosed With Moderna’s COVID-19 Vaccine Candidate
Participants demonstrated high levels of neutralizing antibody activity that exceeded those seen in convalescent sera obtained from persons with confirmed COVID-19.
Model Estimates Herd Immunity Threshold for COVID-19
A mathematical model shows that SARS-CoV-2 disease-induced herd immunity level may be lower than the classical model assuming homogenous immunization.
Pfizer, BioNTech’s COVID-19 Vaccine Candidate Looks Promising in Early Human Trial
Pfizer and BioNTech SE announced positive preliminary results from the phase 1/2 study evaluating the safety, tolerability, and immunogenicity of escalating doses of the vaccine candidate BNT162b1 against COVID-19.
Post-Vaxx Febrile Seizures Not Linked to Child Development Outcomes
Young children experiencing an initial vaccine-proximate (VP) febrile seizure (FS) do not have increased risk of developmental or behavioral problems.
CDC Issues Guidance on Vaccination During the COVID-19 Pandemic
Routine vaccination should not be delayed due to the COVID-19 pandemic, according to interim guidance released by the Centers for Disease Control and Prevention.
Phase 1 Study of Adjuvanted COVID-19 Vaccine Candidate Begins
A phase 1 study evaluating the safety, reactogenicity and immunogenicity of SCB-2019, a vaccine candidate for coronavirus disease 2019 (COVID-19), has been initiated by Clover Biopharmaceuticals.
HPV Vaccine Toolkit Increases Vaccination Rates in Primary Care
The purpose of this project is to implement and evaluate the effectiveness of the 4 Pillars Practice Transformation Program to increase uptake of the HPV vaccine among pediatric patients.
-
Loading...
-
Loading...
Next post in Medicine
